×
Industry Reports Services Press Release
  •   Blogs
  • Contact us About us

    North America Animal Model Market Forecast 2027 By Technology (CRISPR, Microinjection, Embryonic Stem Cell Injection, Nuclear Transfer), By Animal Type (Mice, Rats, Fish, Birds, Cattles, Pigs, Amphibians, Guinea Pigs, Dogs, Cats, Rabbits, Monkeys, Sheep, Hamsters), By Application (Research & Development {Infectious Disease, Immunological Diseases, Cancer, Cardiovascular Diseases, Diabetes, Genetic Diseases, Neurological Diseases, Obesity, NAFLD/NASH, Renal Disease, Diabetic Eye Disease, Fibrosis, Microbiome}, Production and Quality Control, Academics, Preclinical Applications {Infectious Disease, Immunological Diseases, Cancer, Cardiovascular Diseases, Diabetes, Genetic Diseases, Neurological Diseases, Obesity, NAFLD/NASH, Renal Disease, Diabetic Eye Disease, Fibrosis, Microbiome}), By Use (Human, Veterinary), By End-use (Companies {Pharmaceutical, Biotechnology, Cosmetics}, Organizations {Government, Non-government}, Academic and Research Institutes, Contract Research Organizations (CRO)), Research Report, Regional Outlook (U.S., Canada), COVID-19 Impact Statistics, Price Trends, Historic Data, Growth Prospects, Competitive Industry Share
    Published Date: June 2021   |   Report ID: GR1851   |   Delivery: PDF  Request Free Sample

    Report Content

    Chapter 1   Methodology

    1.1    Methodology

    1.2    Market definitions

    1.3    Forecast parameters

    1.4    Data sources

    1.4.1    Secondary

    1.4.1.1    Paid sources

    1.4.1.2    Unpaid sources

    1.4.2    Primary

    Chapter 2   Executive Summary

    2.1    North America animal model industry 3600 synopsis, 2016 - 2027

    2.1.1    Country trends

    2.1.2    Animal type trends

    2.1.3    Technology trends

    2.1.4    Application trends

    2.1.5    Use trends

    2.1.6    End-use trends

    Chapter 3   North America Animal Model Industry Insights

    3.1    Industry segmentation

    3.2    Industry landscape, 2016 - 2027

    3.3    Industry impact forces

    3.3.1    Growth drivers

    3.3.1.1    Growing number of pharmaceutical research and development activities

    3.3.1.2    Large number of applications in healthcare domain

    3.3.1.3    Physiological similarities between human and animal

    3.3.1.4    Emergence of CRISPR as a powerful tool in the field of biomedical research

    3.3.1.5    Growing consumption of personalized medicine driving the demand for humanized mice models

    3.3.2    Industry pitfalls & challenges

    3.3.2.1    Expensive process

    3.3.2.2    Strict regulations and guidelines

    3.3.2.3    Growing opposition on animal testing by several organizations

    3.4    Analysis of COVID-19 impact on the industry

    3.5    Porter’s analysis

    3.6    Competitive landscape, 2020

    3.7    PEST analysis

    Chapter 4   North America Animal Model Market, By Animal Type

    4.1    Market trends

    4.2    Mice

    4.2.1    Market estimate and forecast, by country, 2016 – 2027 (USD Million)

    4.2.2    Market estimate and forecast, by country, 2016 – 2027 (Units)

    4.3    Rats

    4.3.1    Market estimate and forecast, by country, 2016 – 2027 (USD Million)

    4.3.2    Market estimate and forecast, by country, 2016 – 2027 (Units)

    4.4    Fish

    4.4.1    Market estimate and forecast, by country, 2016 – 2027 (USD Million)

    4.4.2    Market estimate and forecast, by country, 2016 – 2027 (Units)

    4.5    Birds

    4.5.1    Market estimate and forecast, by country, 2016 – 2027 (USD Million)

    4.5.2    Market estimate and forecast, by country, 2016 – 2027 (Units)

    4.6    Cattles

    4.6.1    Market estimate and forecast, by country, 2016 – 2027 (USD Million)

    4.6.2    Market estimate and forecast, by country, 2016 – 2027 (Units)

    4.7    Pigs

    4.7.1    Market estimate and forecast, by country, 2016 – 2027 (USD Million)

    4.7.2    Market estimate and forecast, by country, 2016 – 2027 (Units)

    4.8    Amphibians

    4.8.1    Market estimate and forecast, by country, 2016 – 2027 (USD Million)

    4.8.2    Market estimate and forecast, by country, 2016 – 2027 (Units)

    4.9    Guinea Pigs

    4.9.1    Market estimate and forecast, by country, 2016 – 2027 (USD Million)

    4.9.2    Market estimate and forecast, by country, 2016 – 2027 (Units)

    4.10    Dogs

    4.10.1    Market estimate and forecast, by country, 2016 – 2027 (USD Million)

    4.10.2    Market estimate and forecast, by country, 2016 – 2027 (Units)

    4.11    Cats

    4.11.1    Market estimate and forecast, by country, 2016 – 2027 (USD Million)

    4.11.2    Market estimate and forecast, by country, 2016 – 2027 (Units)

    4.12    Rabbits

    4.12.1    Market estimate and forecast, by country, 2016 – 2027 (USD Million)

    4.12.2    Market estimate and forecast, by country, 2016 – 2027 (Units)

    4.13    Monkeys

    4.13.1    Market estimate and forecast, by country, 2016 – 2027 (USD Million)

    4.13.2    Market estimate and forecast, by country, 2016 – 2027 (Units)

    4.14    Sheep

    4.14.1    Market estimate and forecast, by country, 2016 – 2027 (USD Million)

    4.14.2    Market estimate and forecast, by country, 2016 – 2027 (Units)

    4.15    Hamsters

    4.15.1    Market estimate and forecast, by country, 2016 – 2027 (USD Million)

    4.15.2    Market estimate and forecast, by country, 2016 – 2027 (Units)

    4.16    Others

    4.16.1    Market estimate and forecast, by country, 2016 – 2027 (USD Million)

    4.16.2    Market estimate and forecast, by country, 2016 – 2027 (Units)

    Chapter 5   North America Animal Model Market, By Technology

    5.1    Market trends

    5.2    CRISPR

    5.2.1    Market estimate and forecast, by country, 2016 – 2027 (USD Million)

    5.3    Microinjection

    5.3.1    Market estimate and forecast, by country, 2016 – 2027 (USD Million)

    5.4    Embryonic Stem Cell Injection

    5.4.1    Market estimate and forecast, by country, 2016 – 2027 (USD Million)

    5.5    Nuclear Transfer

    5.5.1    Market estimate and forecast, by country, 2016 – 2027 (USD Million)

    5.6    Others

    5.6.1    Market estimate and forecast, by country, 2016 – 2027 (USD Million)

    Chapter 6   North America Animal Model Market, By Application

    6.1    Market trends

    6.2    Research & Development

    6.2.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

    6.2.2    Infectious Disease

    6.2.2.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

    6.2.3    Immunological Disease

    6.2.3.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

    6.2.4    Cancer

    6.2.4.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

    6.2.5    Cardiovascular Disease

    6.2.5.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

    6.2.6    Diabetes

    6.2.6.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

    6.2.7    Genetic Disease

    6.2.7.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

    6.2.8    Neurological Disease

    6.2.8.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

    6.2.9    Obesity

    6.2.9.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

    6.2.10    NAFLD/NASH

    6.2.10.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

    6.2.11    Renal Disease

    6.2.11.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

    6.2.12    Diabetic Eye Disease

    6.2.12.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

    6.2.13    Fibrosis

    6.2.13.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

    6.2.14    Microbiome

    6.2.14.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

    6.2.15    Others

    6.2.15.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

    6.3    Production & Quality Control

    6.3.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

    6.4    Academics

    6.4.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

    6.5    Preclinical Applications

    6.5.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

    6.5.2    Infectious Disease

    6.5.2.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

    6.5.3    Immunological Disease

    6.5.3.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

    6.5.4    Cancer

    6.5.4.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

    6.5.5    Cardiovascular Disease

    6.5.5.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

    6.5.6    Diabetes

    6.5.6.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

    6.5.7    Genetic Disease

    6.5.7.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

    6.5.8    Neurological Disease

    6.5.8.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

    6.5.9    Obesity

    6.5.9.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

    6.5.10    NAFLD/NASH

    6.5.10.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

    6.5.11    Renal Disease

    6.5.11.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

    6.5.12    Diabetic Eye Disease

    6.5.12.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

    6.5.13    Fibrosis

    6.5.13.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

    6.5.14    Microbiome

    6.5.14.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

    6.5.15    Others

    6.5.15.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

    6.6    Others

    6.6.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

    Chapter 7   North America Animal Model Market, By Use

    7.1    Market trends

    7.2    Human

    7.2.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

    7.3    Veterinary

    7.3.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

    Chapter 8   North America Animal Model Market, By End-use

    8.1    Market trends

    8.2    Companies

    8.2.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

    8.2.2    Pharmaceutical

    8.2.2.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

    8.2.3    Biotechnology

    8.2.3.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

    8.2.4    Cosmetics

    8.2.4.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

    8.2.5    Others

    8.2.5.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

    8.3    Organizations

    8.3.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

    8.3.2    Government

    8.3.2.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

    8.3.3    Non-government

    8.3.3.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

    8.4    Academic & Research Institutes

    8.4.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

    8.5    Contract Research Organizations

    8.5.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

    Chapter 9   North America Animal Model Market, By Country

    9.1    Market trends

    9.2    U.S.

    9.2.1    Market estimate and forecast, by animal type, 2016 – 2027 (USD Million)

    9.2.2    Market estimate and forecast, by animal type, 2016 – 2027 (Units)

    9.2.3    Market estimate and forecast, by technology, 2016 – 2027 (USD Million)

    9.2.4    Market estimate and forecast, by application, 2016 – 2027 (USD Million)

    9.2.4.1    Market estimate and forecast, by research & development, 2016 – 2027 (USD Million)

    9.2.4.2    Market estimate and forecast, by preclinical applications, 2016 – 2027 (USD Million)

    9.2.5    Market estimate and forecast, by use, 2016 – 2027 (USD Million)

    9.2.6    Market estimate and forecast, by end-use, 2016 – 2027 (USD Million)

    9.2.6.1    Market estimate and forecast, by companies, 2016 – 2027 (USD Million)

    9.2.6.2    Market estimate and forecast, by organizations, 2016 – 2027 (USD Million)

    9.3    Canada

    9.3.1    Market estimate and forecast, by animal type, 2016 – 2027 (USD Million)

    9.3.2    Market estimate and forecast, by animal type, 2016 – 2027 (Units)

    9.3.3    Market estimate and forecast, by technology, 2016 – 2027 (USD Million)

    9.3.4    Market estimate and forecast, by application, 2016 – 2027 (USD Million)

    9.3.4.1    Market estimate and forecast, by research & development, 2016 – 2027 (USD Million)

    9.3.4.2    Market estimate and forecast, by preclinical applications, 2016 – 2027 (USD Million)

    9.3.5    Market estimate and forecast, by use, 2016 – 2027 (USD Million)

    9.3.6    Market estimate and forecast, by end-use, 2016 – 2027 (USD Million)

    9.3.6.1    Market estimate and forecast, by companies, 2016 – 2027 (USD Million)

    9.3.6.2    Market estimate and forecast, by organizations, 2016 – 2027 (USD Million)

    Chapter 10   Company Profiles

    10.1    Charles River

    10.1.1    Business overview

    10.1.2    Financial data

    10.1.3    Product landscape

    10.1.4    Strategic outlook

    10.1.5    SWOT analysis

    10.2    Envigo

    10.2.1    Business overview

    10.2.2    Financial data

    10.2.3    Product landscape

    10.2.4    Strategic outlook

    10.2.5    SWOT analysis

    10.3    genOway

    10.3.1    Business overview

    10.3.2    Financial data

    10.3.3    Product landscape

    10.3.4    Strategic outlook

    10.3.5    SWOT analysis

    10.4    Harbour BioMed

    10.4.1    Business overview

    10.4.2    Financial data

    10.4.3    Product landscape

    10.4.4    Strategic outlook

    10.4.5    SWOT analysis

    10.5    Janvier Labs

    10.5.1    Business overview

    10.5.2    Financial data

    10.5.3    Product landscape

    10.5.4    Strategic outlook

    10.5.5    SWOT analysis

    10.6    PharmaLegacy

    10.6.1    Business overview

    10.6.2    Financial data

    10.6.3    Product landscape

    10.6.4    Strategic outlook

    10.6.5    SWOT analysis

    10.7    Taconic Biosciences Inc.

    10.7.1    Business overview

    10.7.2    Financial data

    10.7.3    Product landscape

    10.7.4    Strategic outlook

    10.7.5    SWOT analysis

    10.8    The Jackson Laboratory

    10.8.1    Business overview

    10.8.2    Financial data

    10.8.3    Product landscape

    10.8.4    Strategic outlook

    10.8.5    SWOT analysis

    10.9    TRANS GENIC INC, Ltd.

    10.9.1    Business overview

    10.9.2    Financial data

    10.9.3    Product landscape

    10.9.4    Strategic outlook
     


    Get this research report on North America Animal Model Market customized according to your business requirements.

    report-purchase - logo Buy Now

    Why Choose us?

    • on-time delivery On-Time Delivery

      We commit to on-time delivery of reports to keep you ahead.

    • assured quality Assured Quility

      With a wide network of industry experts and trained in-house analysts, we assure best service quality.

    • Custom Research Service

      We offer research services to meet specific client requirements and provide them with actionable insights on target markets.

    • payment security Payment Security

      Our safe payment gateway gives you full control of your personal data, at all times.

    Connect with our sales team

      (+1)-208-273-9852

     [email protected]